Company · Analysis · 29 Oct 2026
Orion Pharma: power revenue fell 88% after the plant contracts expired, leaving a BDT 25.6bn debt load on a pharma business earning BDT 251m
FY2025 consolidated revenue fell 61.6% to BDT 4.08bn and the group lost BDT 415m. The auditor qualified its opinion over a restated UCB loan and a BDT 651m claim on an individual; the shares have been in DSE's Z category since 5-Feb-2025 over an unpaid dividend.
Orion Pharma Limited is a listed generic-medicine maker that also owns two power plants and holds shares in other Orion group companies. It owns 95% of Orion Power Meghnaghat Limited and 67% of Dutch Bangla Power & Associates Limited, each a 100 MW heavy-fuel-oil quick…